Skip to content
★ Sign in to follow
WL

William L. Hunter

Angiotech Pharmaceuticals IncEPIRUS Biopharmaceuticals, Inc.
Total declarations
239
Companies
2
▲ Purchases (207 ops.)
€953k
▼ Sales (0 ops.)
—

Latest filing published 17 May 2011 for ANGIOTECH PHARMACEUTICALS INC.

Filing timeline

BuySale
William L. Hunter

First 200 filings with a declared amount

Insider track record

Disclosed buys
207
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
207

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

William L. Hunter: trading record in brief

William L. Hunter discloses dealings in 2 companies, chiefly Angiotech Pharmaceuticals Inc and EPIRUS Biopharmaceuticals, Inc. Over a trading history stretching from 9 December 2008 to 12 May 2011, the count stands at 239 filings.

The open-market record is one-sided, with 207 purchases worth €953k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant.

In size, the median ticket on the buying side is €338.

The latest filing, published on 17 May 2011, reports a transaction in Angiotech Pharmaceuticals Inc. The last insider purchase was made public on 23 November 2009, 6,194 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to William L. Hunter

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations239 total

25 of 239 declarations